Table 2. Laboratory findings from the second set of tests after hospital admission, from 845 patients grouped according to in-hospital mortality (survivors/non-survivors).
| Variable (units) | Reference range | Total patients N = 845 |
Survivors
N = 695 |
Non-survivors
N = 150 |
P | |
|---|---|---|---|---|---|---|
| Alanine aminotransferase (U/L) | m | < 41 | 26 (17–43) | 26 (17-44) | 27 (17-41) | 0.845 |
| f | < 33 | |||||
| Albumin (g/L) | 35-52 | 36 (33-38) | 36 (33-38) | 33 (30-35) | < 0.001 | |
| Alkaline phosphatase (U/L) | m | < 129 | 61 (50-80) | 61 (50-76) | 65 (54-86) | 0.043 |
| f | < 140 | |||||
| Aspartate aminotransferase (U/L) | m | < 40 | 33 (24-49) | 30 (23-47) | 43 (31-59) | < 0.001 |
| f | < 32 | |||||
| Bilirubin, total (µmol/L) | ≤ 18 | 9 (7-13) | 7 (6-13) | 10 (7-16) | 0.018 | |
| Calcium (mmol/L) | m | 2.20-2.54 | 2.15 (2.06-2.23) | 2.16 (2.07-2.25) | 2.09 (2.03-2.18) | < 0.001 |
| f | 2.15-2.51 | |||||
| C-reactive protein (mg/L) | ≤ 5 | 84 (41-164) | 74 (36-140) | 176 (96-273) | < 0.001 | |
| Creatine kinase (U/L) | m | < 190 | 77 (44-159) | 70 (41-133) | 141 (69-269) | < 0.001 |
| f | < 170 | |||||
| Creatinine (µmol/L) | m | 59-104 | 76 (62-97) | 74 (61-92) | 94 (72-131) | < 0.001 |
| f | 45-84 | |||||
| D- dimer (µg/L) | < 250 | 313 (250-600) | 283 (250-478) | 654 (361-1366) | < 0.001 | |
| Ferritin (µg/L) | 30-400 | 749 (361-1373) | 680 (344-1224) | 1218 (714-2004) | < 0.001 | |
| Gamma-glutamyltransferase (U/L) | m | ≤ 70 | 44 (24-83) | 43 (24-82) | 46 (28-90) | 0.355 |
| f | ≤ 30 | |||||
| Haemoglobin (g/L) | m | 130-165 | 130 (119-140) | 130 (120-140) | 128 (112-139) | 0.089 |
| f | 120-147 | |||||
| Lactate dehydrogenase (U/L) | m | < 225 | 299 (232-384) | 285 (223-355) | 425 (348-538) | < 0. 001 |
| f | < 214 | |||||
| Leukocytes (× 109/L) | 3.9-9.5 | 6.0 (5.0-8.0) | 6.0 (5.0-8.0) | 8.0 (5.0-10.0) | < 0.001 | |
| Lymphocytes (× 109/L) | 1.3-3.4 | 1.0 (0.7-1.4) | 1.1 (0.8-1.4) | 0.6 (0.4-0.8) | < 0.001 | |
| Neutrophils (× 109/L) | 1.5-5.7 | 4.3 (3.0-6.4) | 4.1 (2.9-5.9) | 6.4 (4.0-9.1) | < 0.001 | |
| Platelets (× 109/L) | m | 149-303 | 214 (159-279) | 219 (165-283) | 194 (149-257) | 0.003 |
| f | 153-368 | |||||
| Potassium (mmol/L) | 3.83-5.10 | 4.00 (3.68-4.31) | 3.98 (3.68-4.29) | 4.04 (3.72-4.48) | 0.061 | |
| Troponin T (ng/L) | ≤ 14 | 11 (7-20) | 9 (7-17) | 20 (12-36) | < 0.001 | |
| Data are reported as median (IQR). P values indicate differences between survivors and non-survivors. Results where P < 0.05 were considered statistically significant. m – male. f – female. IQR – interquartile range. | ||||||